2004•Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Cost-effectiveness of Sequntial Therapy of Levofloxacin in Subaspiratory Bacterial Infection

Yan Wang

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate pharmacoeconomic effect of sequntial therapy of levofloxacin on subaspiratory bacterial infection. METHODS: 180 cases with subaspiratory bacterial infection were randomly divided into group A and group B, 90 patients were in each group. Levofloxacin was given by continuous intravenous infusion in group A, and both levofloxacin injection and tablets by sequntial therapy were given in group B. Two schemes were analyzed by minimal cost analysis of pharmacoeconomics. RESULTS:There was no significant difference ( P 0.05) among clinical curative effect, adverse-effect and germ-clearance, but the expenses in group A were higher than that in group B ( P 0.01). CONCLUSION:It is safe, effective,economic and rational for the patients with subaspiratory bacterial infection by sequntial therapy of levofloxacin injection with levofloxacin tablets.

About this research paper

What this paper is about

OBJECTIVE:To evaluate pharmacoeconomic effect of sequntial therapy of levofloxacin on subaspiratory bacterial infection. METHODS: 180 cases with subaspiratory bacterial infection were randomly divided into group A and group B, 90 patients were in each group. Levofloxacin was given by continuous intravenous infusion in group A, and both levofloxacin injection and tablets by sequntial therapy were given in group B. Two schemes were analyzed by minimal cost analysis of pharmacoeconomics. RESULTS:There was no significant difference ( P 0.05) among clinical curative effect, adverse-effect and germ-clearance, but the expenses in group A were higher than that in group B ( P 0.01). CONCLUSION:It is safe, effective,economic and rational for the patients with subaspiratory bacterial infection by sequntial therapy of levofloxacin injection with levofloxacin tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate pharmacoeconomic effect of sequntial therapy of levofloxacin on subaspiratory bacterial infection. METHODS: 180 cases with subaspiratory bacterial infection were randomly divided into group A and group B, 90 patients were in each group. Levofloxacin was given by continuous intravenous infusion in group A, and both levofloxacin injection and tablets by sequntial therapy were given in group B. Two schemes were analyzed by minimal cost analysis of pharmacoeconomics. RESULTS:There was no significant difference ( P 0.05) among clinical curative effect, adverse-effect and germ-clearance, but the expenses in group A were higher than that in group B ( P 0.01). CONCLUSION:It is safe, effective,economic and rational for the patients with subaspiratory bacterial infection by sequntial therapy of levofloxacin injection with levofloxacin tablets.

Key concepts: Levofloxacin, Medicine, Pharmacoeconomics, Adverse effect, Internal medicine, Group A, Group B, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Cost-effectiveness of Sequntial Therapy of Levofloxacin in Subaspiratory Bacterial Infection — Research Paper | ScholarLens